In today’s newsletter, Ida Jooste discusses what the Global Fund phase-out means for HIV programmes in South Africa. Sign up ...
The uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the ...
New research shows a steep decline in adolescent pregnancy rates across all nine provinces from 2021 to 2025, reversing ...
Experts say South Africa's contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a worsening crisis in places like Westbury, where illicit drugs plague the ...
Thirty years ago, having a drink or two every day was thought to be good for your heart — thanks in part to the so-called French paradox. But research now shows that even a little alcohol can up the ...
In today’s newsletter, Linda Pretorius looks at how gathering data helped shape South Africa’s HIV plans. Sign up today. Numbers put us in the know. We saw that with COVID-19, and now again, with ...
The scientists in South Africa who alerted the world about the Omicron variant are now unable to access enough of the chemicals they need to keep tracking the virus. The travel bans on southern ...
In today’s newsletter, our editor-in-chief Mia Malan and content editor Linda Pretorius look at what it may cost South Africa to supply HIV-prevention drug lenacapavir. Sign up for our newsletter now.
In today’s newsletter, Mia Malan asks who in SA should get LEN first. Sign up for our newsletter today. One in ten clinics in South Africa — across 22 health districts in six provinces — could start ...
In today’s newsletter, Linda Pretorius explains the numbers behind what LEN can do for SA. Sign up for our newsletter today. South Africa’s first batch of the once-every-six-months HIV prevention shot ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results